An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability, safety and treatment response of
flexible doses of paliperidone extended-release (ER; designed to slowly release a drug in the
body over an extended period of time) tablets in participants with acute schizophrenia
(psychiatric disorder with symptoms of emotional instability, detachment from reality, often
with delusions and hallucinations, and withdrawal into the self).